Abstract:DNA origami “Trojan horse” nanostructures provide an effective delivery approach to circumvent drug resistance in leukemia cells. These 100 nanometer delivery vehicles, described on page 308 by C. E. Castro and co‐workers, are easily fabricated in 10 min and can be precisely loaded with commonly used anthracycline chemotherapeutic drugs. Drug‐loaded DNA origami nanostructures enter cells via endocytosis, allowing the drug to bypass defenses in the cell membrane that are effective against free drug. This approa… Show more
“…Taken together, these recent strategies demonstrate the ability to co-formulate multiple targeting and gene therapeutic modalities, as well as endow specific triggering and responsive properties in cellular pathways of interest. While significant fundamental work is still required to better characterize the efficacy of these formulations in vivo compared with standard, competing delivery technologies such as LNPs, together with a growing list of other therapeutic formulations and capabilities [29] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , NANPs offer promising avenues for further research into potentially clinically relevant modalities. …”
“…Taken together, these recent strategies demonstrate the ability to co-formulate multiple targeting and gene therapeutic modalities, as well as endow specific triggering and responsive properties in cellular pathways of interest. While significant fundamental work is still required to better characterize the efficacy of these formulations in vivo compared with standard, competing delivery technologies such as LNPs, together with a growing list of other therapeutic formulations and capabilities [29] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , NANPs offer promising avenues for further research into potentially clinically relevant modalities. …”
“…The DNA origami method uses Watson–Crick base-pairing to direct the folding of a long single-stranded piece of DNA (ssDNA) (the scaffold) with a set of complementary oligodeoxyribonucleotide (ODN) strands (staples), whose rational design leads to the creation of intricate two- and three-dimensional nanostructures. − The modularity of DNA origami and the accessibility of a defined ssDNA template makes this approach one of the most versatile methods to predictably and reproducibly prepare nanostructures in the 100 nm regime. Furthermore, the incorporation of recognition elements in ODN staples permits the spatial arrangement of components with subnanometer precision, providing additional functionality for applications spanning biosensing, drug delivery, and the fabrication of photonic devices. − …”
An orthogonal, noncovalent approach to direct the assembly of higher-order DNA origami nanostructures is described. By incorporating perfluorinated tags into the edges of DNA origami tiles we control their hierarchical assembly via fluorous-directed recognition. When we combine this approach with Watson−Crick base-pairing we form discrete dimeric constructs in significantly higher yield (8x) than when either molecular recognition method is used in isolation. This integrated "catch-and-latch" approach, which combines the strength and mobility of the fluorous effect with the specificity of base-pairing, provides an additional toolset for DNA nanotechnology, one that enables increased assembly efficiency while requiring significantly fewer DNA sequences. As a result, our integration of fluorous-directed assembly into origami systems represents a cheap, atom-efficient means to produce discrete superstructures.
“…[12][13][14] DONs are functional as immune-activating programmable adjuvants, [15,16] and they can be used as drug-delivery vehicles to circumvent drug resistance. [17][18][19][20] These studies have suggested that intracellular DON uptake is usually dependent on endocytosis. [18] Furthermore, DONs can bind to the outside of the cells to stimulate cellular transmembrane receptors.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, it has been demonstrated that DONs are stable reagents under cell culturing conditions . DONs are functional as immune‐activating programmable adjuvants, and they can be used as drug‐delivery vehicles to circumvent drug resistance . These studies have suggested that intracellular DON uptake is usually dependent on endocytosis .…”
The unique structure‐directing properties of DNA origami nanostructures (DONs) show great potential to specifically manipulate intracellular processes. We report an innovative concept to selectively activate the transcription of a single gene in the developing zebrafish embryo. We reason that engineering a designer transcription factor in which a rigid DON imposes a fixed distance between the DNA‐binding domain (DBD) and the transactivation domain (TAD) would allow the selective activation of a gene harboring the same distance between the corresponding transcription factor binding site and the core promoter. As a test case, a rigid tubular DON was designed to separate the DBD of the GAL4 transcription factor and the VP16 viral protein as a TAD. This construct was microinjected in the yolk of one‐cell‐stage zebrafish embryos, together with a reporter plasmid to assess its functionality. The large DON was efficiently distributed to cells of the developing embryo and showed no signs of toxicity. However, because the DON showed only a cytosolic localization, it did not activate transcription of the reporter gene. Although this work clearly demonstrates that DON microinjection enables the intracellular distribution of multi‐protein architectures in most of the cells of the developing zebrafish embryo, further refinements are necessary to enable selective gene activation in vivo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.